ACS Community Access to Resources Education and Support - Trial NCT06285929
Access comprehensive clinical trial information for NCT06285929 through Pure Global AI's free database. This phase not specified trial is sponsored by American Cancer Society, Inc. and is currently Enrolling by invitation. The study focuses on Neoplasms. Target enrollment is 2000 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
American Cancer Society, Inc.
Timeline & Enrollment
N/A
Sep 01, 2023
Dec 31, 2025
Primary Outcome
Measure the impact of ACS CARES on patient-reported outcomes: SDOH barriers,Measure the impact of ACS CARES on patient-reported outcomes: Information Needs,Measure the impact of ACS CARES on patient-reported outcomes: Distress needs,Measure the impact of ACS CARES on patient-reported outcomes: Satisfaction with program,Measure the impact of ACS CARES on patient-reported outcomes: Unmet needs,Measure the impact of ACS CARES on patient-reported outcomes: Patient-provider communication,Measure the impact of ACS CARES on patient-reported outcomes: clinical trials knowledge,Measure the impact of ACS CARES on patient-reported outcomes: Patient activation,Measure the impact of ACS CARES on patient-reported outcomes: Financial toxicity,Measure the impact of ACS CARES on patient-reported outcomes: Quality of life,Context, Training, and Process Measures: Service Penetrance and Process Measures: Service Penetrance
Summary
The goal of this study is to evaluate the pilot phase of ACS Cares to identify key
 implementation outcomes and assess effectiveness of the program to improve distress, enhance
 communication, and reduce missed appointments and healthcare utilization.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06285929
Non-Device Trial